FDA Approves First 'Biosimilar' Drug Zarxio Paving Way For More Affordable Drugs The FDA has approved Zarxio, the first biosimilar drug in the U.S. More than 40 countries already use Zarxio to prevent infections in cancer patients receiving chemotherapy. by Sumit Passary
Healthy Living/Wellness Novartis Version of Amgen Cancer Drug Just as Good as Original by Dianne Depra
China Launches World's Largest Electric Container Ship, Slashing 8,600 Pounds of Emissions per 100 Nautical Miles